Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Cervical Cancer Diagnostics Market Size - By Diagnostic Methods (Pap Smear Tests, HPV DNA Tests, Colposcopy, Biopsy and Endocervical Curettage), Age Group (20-40 Years, Above 40 Years), End-use (Hospitals, Diagnostic Imaging Centres) & Forecast, 2024-2032
... Cervical Cancer Diagnostics Market size is estimated to expand at over 5.3% CAGR from 2024 to 2032, on account of the increasing awareness about the importance of early detection and screening programs for cervical cancer. ... Read More
-
Cancer biologics Global Market Report 2024
... Cancer; Colorectal Cancer; Gastric Cancers3) By Distribution Channel: Hospitals; ClinicsCovering: AbbVie Inc.; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Eli Lilly and Company; AmgenInc. Cancer biologics Global Market Report 2024 from The Business Research Company provides ... Read More
-
Multi-Cancer Diagnostic Tests: Global Market Outlook
... of the drivers and challenges in the market. The report also covers market projections for 2028. The report details the market share of MCD tests based on type and end user. The market is segmented ... Read More
-
Breast Cancer Monoclonal Antibodies Global Market Report 2024
... Covering: Amgen Inc.; Mylan N.V.; Merck & Co. Inc.; Novartis AG; GlaxoSmithKline plc. Breast Cancer Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Global POC Analyzers for Cancer Market Growth 2024-2030
... at a CAGR of % from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “POC Analyzers for Cancer Industry Forecast” looks at past sales and reviews total world POC Analyzers for ... Read More
-
Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region- Global Forecast to 2028
... home healthcare market is projected to reach USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, at a CAGR of 8.9% during the forecast period. The primary driver of growth in this market ... Read More
-
North America Cancer Diagnostics Market, By Products (Instruments, Consumables Services), By Test Type (Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Immunohistochemistry, In Situ Hybridization and Others (Endoscopy, Genetic Tests)), By Application (Breast Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Liver Cancer, Others (Including Skin Cancer, Colorectal Cancer, Prostate Cancer, etc.)), By End User (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, Others), By Country (United ... Read More
-
Kaposi Sarcoma Market Forecasts to 2030 – Global Analysis By Type (Classic Kaposi Sarcoma, Endemic Kaposi Sarcoma, Epidemic Kaposi Sarcoma, Immunosuppression-Associated Kaposi Sarcoma, Latrogenic Kaposi Sarcoma, Disseminated Kaposi Sarcoma and Other Types), Diagnostic Method, Treatment Modality, End User and By Geography
... Modality, End User and By Geography According to Stratistics MRC, the Global Kaposi Sarcoma Market is accounted for $108.69 million in 2023 and is expected to reach $150.92 million by 2030 growing at a CAGR ... Read More
-
Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
... according to Renub Research. In modern-day healthcare, lung cancer diagnostics are pivotal in early detection and personalized treatment. Advanced imaging strategies like CT scans and MRI permit particular identification of tumors and metastases, assisting in ... Read More
-
Genomics In Cancer Care Global Market Report 2024
... By End-user: Hospitals; Government Institutes; Research FacilitiesCovering: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V. Genomics In Cancer Care Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Global Anticancer Drugs Market Research Report 2024
... during the forecast period 2024-2030. North American market for Anticancer Drugs is estimated to increase from $ 104,835 million in 2023 to reach $ 207,068 million by 2030, at a CAGR of 10.7% during the ... Read More
-
Advanced Renal Cell Carcinoma- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034
... RR-FL; however, follow-up remains limited. Identifying appropriate patients for CAR T-cell therapy stands out as a paramount challenge, given its expensive nature and aggressive treatment approach. The FDA has approved four CAR-Ts in different subtypes ... Read More
-
Peripheral T-Cell Lymphoma Market Insight, Epidemiology And Market Forecast - 2034
... crucial retinal components such as retinal pigment epithelium (RPE), photoreceptors, and choriocapillaris in the macula. Although this condition is not uncommon in clinical practice, it can go undetected until the atrophy involves the fovea and ... Read More
-
Esophageal Cancer - Market Insight, Epidemiology And Market Forecast - 2034
... million, which is further expected to increase by 2034. In September 2023, concizumab was approved in Japan under the brand name ALHEMO for treating hemophilia A and B with inhibitors. Novo Nordisk expects to launch ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Cancer Biomarker Global Market Report 2024
... Cancer; Thyroid Cancer; Kidney Cancer4) By Application: Diagnostics; Research And Development; Prognostics; Risk AssessmentCovering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; QIAGEN NV; Illumina Inc.; Bio-Rad Laboratories Inc. Cancer Biomarker Global Market Report 2024 ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032
... for approximately USD 1,300 million, which is further expected to increase by 2034. Epidermolysis bullosa simplex (EBS) is the least severe type of epidermolysis bullosa, and many individuals with EBS may experience improvements as they ... Read More
-
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
... recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and provides forecasts for 2023 through 2028. Figures for 2023 are ... Read More
-
Asia-Pacific EV-Based Liquid Biopsy Market: Analysis and Forecast, 2023-2032
... at a CAGR of 21.64% during the forecast period. The market for EV-based liquid biopsy is anticipated to see growth propelled by continuous technological progress, rising acceptance by healthcare providers, and an increasing emphasis on ... Read More
-
Acute Myeloid Leukemia Market - By Disease (Myeloblastic, Myelomonocytic, Promyelocytic), Treatment (Chemotherapy, Targeted Therapy), Route of Administration (Oral, Parenteral), End-user (Hospital, Clinic, Specialty Center) & Forecast 2024 - 2032
... will grow at 10.7% CAGR from 2024 to 2032, propelled by regulatory approvals for novel drugs and therapies for the disease treatment. Rapid advancements in treatment options and the ongoing R&D efforts are providing patients ... Read More
-
Absorbable Tissue Spacer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... in 2024 to USD 725.76 million by 2029, at a CAGR of 16.79% during the forecast period (2024-2029). The COVID-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many ... Read More
-
Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2024-2032
... of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2024-2032 The Thailand medical cannabis market size reached US$ 187.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,328.2 Million ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
Research Assistance
